Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Remodeling in ocular allergic diseases].

Ken Fukuda1, Naoki Kumagai, Youichiro Fujitsu

  • 1Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube City, Japan. k.fukuda@yamaguchi-u.ac.jp

Nippon Ganka Gakkai Zasshi
|October 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same author

Inhibition of STAT6 signaling by rebamipide attenuates IL-4- and IL-13-induced eotaxin expression in corneal fibroblasts.

Experimental eye research·2026
Same author

A Case of Recurrent Painful Ophthalmoplegic Neuropathy with Frequent Relapses and Prophylaxis with High-Dose Vitamin B2 Supplementation.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Clinical performance of the multiplex solid-phase "Direct Strip PCR" for infectious uveitis: a multicenter diagnostic accuracy study.

Japanese journal of ophthalmology·2026
Same author

Vitreous Incarceration in a Glaucoma Tube Visualized by Asteroid Hyalosis.

Ophthalmology. Glaucoma·2026
Same author

Paradoxical Development of IgG4-Related Ophthalmic Disease During Dupilumab Therapy.

Seminars in ophthalmology·2026
Same journal

Guidance of Medical Care for Familial Exudative Vitreoretinopathy：Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants.

Nippon Ganka Gakkai zasshi·2018
Same journal

Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine.

Nippon Ganka Gakkai zasshi·2018
Same journal

The Effect of Low-dose Cyclosporine (100 mg Once Daily) for Chronic Vogt-Koyanagi-Harada Disease.

Nippon Ganka Gakkai zasshi·2018
Same journal

Clinical Classification of Degree of Deficiency in Color Defectiveness: Simulations by Changing the Total Number of Caps or Saturation of Farnsworth Dichotomous Test D-15.

Nippon Ganka Gakkai zasshi·2018
Same journal

Accelerated Epithelial Proliferation in a Rabbit Model of Bullous Keratopathy.

Nippon Ganka Gakkai zasshi·2018
Same journal

Non-infectious Uveitis and Immunosuppressants：Where We Stand and What the Future Holds.

Nippon Ganka Gakkai zasshi·2018
See all related articles

Vernal keratoconjunctivitis (VKC) involves tissue remodeling, leading to giant papillae and corneal plaques. Activated fibroblasts drive this ocular allergic inflammation, suggesting tissue remodeling as a therapeutic target.

Area of Science:

  • Ophthalmology and immunology
  • Cell biology and tissue engineering

Context:

  • Vernal keratoconjunctivitis (VKC) is a chronic, severe ocular allergic disease.
  • VKC is characterized by significant tissue remodeling, including giant papillae and corneal plaques.

Purpose:

  • To elucidate the role of tissue remodeling in VKC pathogenesis.
  • To identify key cellular mechanisms driving VKC-associated ocular surface changes.

Summary:

  • Giant papillae result from inflammatory cell infiltration, epithelial changes, extracellular matrix deposition, fibroblast proliferation, and neovascularization.
  • Corneal plaques form due to epithelial defects, hindering epithelial cell adhesion and migration.
  • Activated fibroblasts are implicated in initiating and amplifying allergic inflammation and tissue remodeling in VKC.

Related Experiment Videos

Impact:

  • Understanding tissue remodeling mechanisms provides insights into VKC pathology.
  • Tissue remodeling emerges as a potential therapeutic target for managing VKC and its associated corneal complications.